What is Tulsa?

The TULSA-PRO^® system is a customizable and predictable ablation process where Dr. Scionit defines a region of treatment in the prostate while actively protecting the urethra and rectum to help preserve a patient’s urinary and sexual function. TULSA treatment should be performed by a urologist with expertise in prostate cancer ablation.

Watch the video below as Dr. Scionti narrates how the TULSA Pro process.

Is Tulsa Effective?

The MRI‑guided TULSA‑PRO procedure has emerged as a promising treatment option for men with localized low- to intermediate‑risk prostate cancer. Clinical studies show that within one year of treatment, PSA levels dropped by over 70%, prostate volume decreased by more than 50%, and around 65% of patients exhibited no cancer on follow‑up biopsy—while only about 6% required additional (salvage) interventions  . Moreover, the TACT trial data used for FDA approval demonstrated a 95% reduction in average PSA two years post‑procedure, an 80% histological response rate at 12‑months, and just 7% needing further treatment after 2 years  . Side effects are typically minimal: urinary incontinence occurs in about 2–3% of cases, and erectile dysfunction in roughly 20–25%—significantly lower than conventional surgery or radiation  .

Am I a Canidate for TULSA Pro™

Men with localized low‑ or intermediate‑risk prostate cancer—especially those whose tumors are MRI‑visible and confined to one side of the prostate—are the ideal candidates for TULSA‑PRO. Key suitability criteria include Gleason grade group 2 or 3 (particularly unilateral disease), PSA ≤ 20 ng/mL, and disease within approximately 3 cm of the urethral probe location . Patients must also be able to undergo MRI and general anesthesia, and should not have prostatic calcifications larger than about 3 mm, prior prostate implants, urethral strictures, or tumors near structures like the sphincter or neurovascular bundles where accurate thermal targeting is challenging .

Before a referral to TULSA‑PRO can be made, physicians will review your prostate MRI images, biopsy report, PSA history, and overall health to assess candidacy. If your cancer is focal, MRI‑visible, and you meet safety criteria, TULSA may be a customizable option—whether focal, hemi‑gland, or whole‑gland ablation—offered at specialized centers .